CCR5 as a potential target in cancer therapy: inhibition or stimulation?
about
Recent Advances in Discovering the Role of CCL5 in Metastatic Breast CancerCX3CL1 promotes breast cancer via transactivation of the EGF pathwayCX3CL1 at the crossroad of EGF signals: Relevance for the progression of ERBB2(+) breast carcinoma.C-C motif chemokine receptors in gastric cancer.The Expanding Therapeutic Perspective of CCR5 Blockade.
P2860
CCR5 as a potential target in cancer therapy: inhibition or stimulation?
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
CCR5 as a potential target in cancer therapy: inhibition or stimulation?
@en
type
label
CCR5 as a potential target in cancer therapy: inhibition or stimulation?
@en
prefLabel
CCR5 as a potential target in cancer therapy: inhibition or stimulation?
@en
P1476
CCR5 as a potential target in cancer therapy: inhibition or stimulation?
@en
P2093
Emilia Mira
Santos Mañes
P304
P356
10.2174/187152012803529637
P577
2012-11-01T00:00:00Z